Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmEng International | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PharmEng International

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PharmEng International, Inc. has appointed John Durham as corporate vice president, business development for Keata Pharma, Inc., a wholly owned subsidiary of PharmEng. Keata has pharmaceutical contract manufacturing facilities in Arnprior, ON and new facilities in Sydney, Nova Scotia that provide formulation development and testing services to manufacture and package products in solid and liquid dosage forms, including aseptic manufacturing.
   
Prior to joining the company, Mr. Durham was president of the Draxis Pharma Division of Draxis Health, Inc., responsible for pharmaceutical contract manufacturing operations including business development, strategic planning, supply chain and logistics. He has also held senior positions with Banner Pharmaceuticals, Novartis Canada and McNeil Consumer Products.  
   
“I am certain that John’s extensive management experience and strong health science background will be of great benefit to Keata,” said Alan Kwong, CEO of PharmEng International Inc. “His reputation and proven track record in the sector makes him well-suited for his new responsibilities at Keata. He will be a strong addition to the senior management team as we build the book of business for Keata,” concludes Mr. Kwong.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics